ARS Pharmaceuticals Overview

ARS Pharmaceuticals Gross Profit

Gross Profit analysis for SPRY.

Quarterly Gross Profit

N/A

As of Mar 31, 2026

Annual Gross Profit (TTM)

$59.93M

↓ 30.93% YoY

Trailing 12 months ending Mar 31, 2026

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin